Search

Plant resources are used, managed and conserved by local communities in many parts of the world. However, very few studies have examined the site-specific factors and mechanisms that affect resource extraction. We apply methodology from the social and biological sciences to examine the cultural and socio-economic factors that influence the harvest practice and resource use of indigenous wood carvers in the Maningrida region of central Arnhem Land. Woodcarvers from this region use a small number of carving timbers with two species dominant, Bombax ceiba and Brachychiton diversifolius. There were many cultural differences in harvest practice, with artists from the Kuninjku/Kunibeidji language community harvesting a greater number of tree species, larger quantities per harvest trip and smaller sized stems. Socio-economic factors also played an important role in facilitating the collection of stems as artists owning a vehicle acquired more stems than those who did not. Harvest sites closest to the township of Maningrida had higher visitation frequencies than those further away. These influences on harvest practice have significant implications for the ecological sustainability of timber harvesting in this region and we highlight the need to examine such localised factors when assessing the sustainability of indigenous wildlife harvests. [ABSTRACT FROM AUTHOR]

Throughout the world, there are imperatives and opportunities to develop sustainable enterprises based on plants and animals to alleviate poverty. This is true for indigenous people across northern Australia, although to date there has been very limited commercial use of wildlife within indigenous Australian communities. In this study, we examine factors affecting the establishment of enterprises utilising animal species in remote indigenous communities and suggest ways of improving uptake. We found four major areas affecting the progress of these enterprises: a lack of comprehensive market information and dissemination of that knowledge; a lack of basic infrastructure and training; a need for more appropriate and flexible government policy and regulation; and adverse public perceptions. Commercialisation of native species is at a relatively early stage compared to tropical Asia, Africa and South America, and development of these enterprises has the potential to benefit indigenous livelihoods in remote and marginal areas in Australia. [ABSTRACT FROM AUTHOR]

Abstract: In the fungus Neurospora crassa we have used RIP to obtain a presumptive null mutation of the phospholipase C-1 gene, thought to be important in intracellular calcium signaling, notably maintenance of the tip-high calcium gradient. The mutant is viable but has slow, aberrant growth and branching. Hence plc-1 is not required for polar growth at the tip, but is necessary to modulate growth to give normal form. The mutant has residual PLC activity suggesting that this enzyme function can be provided from other parts of the genome. Sequencing natural isolates has shown that the plc-1 gene is highly variable in nature. A large proportion of the variable sites are in a region that is unique to Neurospora. A phylogeny for this gene shows that New and Old World strains have diverged the most. Within the Americas, morphs are found throughout the continent suggesting extensive strain dispersal. [Copyright &y& Elsevier]

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to an unprecedented global health crisis, resulting in a critical need for effective vaccines that generate protective antibodies. Protein subunit vaccines represent a promising approach but often lack the immunogenicity required for strong immune stimulation. To overcome this challenge, it is first demonstrated that advanced biomaterials can be leveraged to boost the effectiveness of SARS‐CoV‐2 protein subunit vaccines. Additionally, it is reported that oxygen is a powerful immunological co‐adjuvant and has an ability to further potentiate vaccine potency. In preclinical studies, mice immunized with an oxygen‐generating coronavirus disease 2019 (COVID‐19) cryogel‐based vaccine (O2‐CryogelVAX) exhibit a robust Th1 and Th2 immune response, leading to a sustained production of highly effective neutralizing antibodies against the virus. Even with a single immunization, O2‐CryogelVAX achieves high antibody titers within 21 days, and both binding and neutralizing antibody levels are further increased after a second dose. Engineering a potent vaccine system that generates sufficient neutralizing antibodies after one dose is a preferred strategy amid vaccine shortage. The data suggest that this platform is a promising technology to reinforce vaccine‐driven immunostimulation and is applicable to current and emerging infectious diseases. [ABSTRACT FROM AUTHOR]

Ebola virus (EBOV), of the family Filoviridae, is an RNA virus that can cause a hemorrhagic fever with a high mortality rate. Defective viral genomes (DVGs) are truncated genomes that have been observed during multiple RNA virus infections, including in vitro EBOV infection, and have previously been associated with viral persistence and immunostimulatory activity. As DVGs have been detected in cells persistently infected with EBOV, we hypothesized that DVGs may also accumulate during viral replication in filovirus-infected hosts. Therefore, we interrogated sequence data from serum and tissue samples using a bioinformatics tool in order to identify the presence of DVGs in nonhuman primates (NHPs) infected with EBOV, Sudan virus (SUDV), or Marburg virus (MARV). Multiple 59 copy-back DVGs (cbDVGs) were detected in NHP serum during the acute phase of filovirus infection. While the relative abundance of total DVGs in most animals was low, serum collected during acute EBOV and SUDV infections, but not MARV infections, contained a higher proportion of short trailer sequence cbDVGs than the challenge stock. This indicated an accumulation of these DVGs throughout infection, potentially due to the preferential replication of short DVGs over the longer viral genome. Using reverse transcriptase PCR (RT-PCR) and deep sequencing, we also confirmed the presence of 59 cbDVGs in EBOV-infected NHP testes, which is of interest due to EBOV persistence in semen of male survivors of infection. This work suggests that DVGs play a role in EBOV infection in vivo and that further study will lead to a better understanding of EBOV pathogenesis. [ABSTRACT FROM AUTHOR]

Discusses a study that investigated cell death pathway using the ultrastructural changes and internucleosomal DNA fragmentation patterns of senescing kalilo strains of Neurospora. Occurrence of cell death in multicellular organisms; Features of apoptosis; Analysis of DNA fragmentation.

Summary 1. More than half of all Australian bandicoot species (family Peramelidae) are listed by the IUCN as extinct or threatened and changed fire regimes in arid and semi-arid Australia have been identified as an important agent in their decline. The northern brown bandicoot is currently one of Australia's most common bandicoots, but their continued persistence in the tropical savannas cannot be taken for granted. Previous studies in Kakadu National Park, Northern Territory have shown this species to be prone to sudden declines in abundance, possibly linked to the occurrence of intense fires. 2. Here we examine the impact of four experimental fire management regimes (fire prevention, early dry season burning, late dry season burning and progressive burning several times through the dry season) on survival of the northern brown bandicoot. The analysis is based on capture–mark–recapture data obtained during a landscape-scale fire experiment conducted at Kapalga, in Kakadu National Park from 1989 to 1995. 3. All experimental fire treatments (including total fire exclusion) were associated with decline in survival rates over time, indicating that none of the tested approaches were appropriate for this species. Burning in the late dry season or progressively throughout the dry season produced substantially more severe declines in survival than did early dry season fires or fire exclusion. 4. Fire regime was found to be the most important determinant of bandicoot survival, far exceeding other factors such as gender, age, vegetation type, rainfall and season, all of which had comparatively little influence. The results demonstrate the importance of the frequency and seasonal timing of fires in determining the survival of bandicoots and suggest that spatially uniform and temporally invariant fire regimes are inappropriate for bandicoot conservation in the north Australian savannas. [ABSTRACT FROM AUTHOR]

Abstract The impact of SO2 dry deposition from mining emissions on cricket abundance, diversity and composition was investigated at Mount Isa in the semiarid tropics of northern Australia. Seventy-one sites were sampled, stratified at two levels: sulphur deposition zones (high, medium, low, and background zones) and habitat (rocky ridge, rocky plain and alluvial plain). The three habitats did not support distinctly different cricket assemblages. Crickets responded to SO2 emissions, but impacts were largely restricted to the high-sulphur zone. Generalised linear modelling showed significant reductions in the probability of presence in the high-sulphur zone for the three genera Eurepella, Salmanites and Endacusta , and the subfamily Eneopterinae. In ordination space, the three high-sulphur zone by habitat combinations were clearly separated from all other combinations, and vector fitting of environmental variables showed soil SO4 to be a primary correlative factor of this separation. Crickets are sensitive to SO2 emissions and they appear to be a good indicator group in this context. [ABSTRACT FROM AUTHOR]

Filoviruses (Family Filoviridae genera Ebolavirus and Marburgvirus) are negative-stranded RNA viruses that cause severe health effects in humans and non-human primates, including death. Except in outbreak settings, vaccines and other medical countermeasures against Ebola virus (EBOV) will require testing under the FDA Animal Rule. Multiple vaccine candidates have been evaluated using cynomolgus monkeys (CM) exposed to EBOV Kikwit strain. To the best of our knowledge, however, animal model development data supporting the use of CM in vaccine research have not been submitted to the FDA. This study describes a large CM database (122 CM, 62 female and 60 male, age 2 to 9 years) and demonstrates the consistency of the CM model through time to death models and descriptive statistics. CMs were exposed to EBOV doses of 0.1 to 100,000 PFU in 33 studies conducted at three Animal Biosafety Level 4 facilities, by three exposure routes. Time to death was modeled using Cox proportional hazards models with a frailty term that incorporated study-to-study variability. Despite significant differences attributed to exposure variables, all CMs exposed to the 100 to 1,000 pfu doses commonly used in vaccine studies died or met euthanasia criteria within 21 days of exposure, median 7 days, 93% between 5 and 12 days of exposure. Moderate clinical signs were observed 4 to 5 days after exposure and preceded death or euthanasia by approximately one day. Viremia was detected within a few days of infection. Hematology indices were indicative of viremia and the propensity for hemorrhage with progression of Ebola viremia. Changes associated with coagulation parameters and platelets were consistent with coagulation disruption. Changes in leukocyte profiles were indicative of an acute inflammatory response. Increased liver enzymes were observed shortly after exposure. Taken together, these factors suggest that the cynomolgus monkey is a reliable animal model for human disease. [ABSTRACT FROM AUTHOR]

While the ongoing COVID‐19 pandemic affirms an urgent global need for effective vaccines as second and third infection waves are spreading worldwide and generating new mutant virus strains, it has also revealed the importance of mitigating the transmission of SARS‐CoV‐2 through the introduction of restrictive social practices. Here, it is demonstrated that an architecturally‐ and chemically‐diverse family of nanostructured anionic polymers yield a rapid and continuous disinfecting alternative to inactivate coronaviruses and prevent their transmission from contact with contaminated surfaces. Operating on a dramatic pH‐drop mechanism along the polymer/pathogen interface, polymers of this archetype inactivate the SARS‐CoV‐2 virus, as well as a human coronavirus surrogate (HCoV‐229E), to the minimum detection limit within minutes. Application of these anionic polymers to frequently touched surfaces in medical, educational, and public‐transportation facilities, or personal protection equipment, can provide rapid and repetitive protection without detrimental health or environmental complications. [ABSTRACT FROM AUTHOR]

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has devastated global public health systems and economies, with over 52 million people infected, millions of jobs and businesses lost, and more than 1 million deaths recorded to date. Contact with surfaces contaminated with droplets generated by infected persons through exhaling, talking, coughing and sneezing is a major driver of SARS-CoV-2 transmission, with the virus being able to survive on surfaces for extended periods of time. To interrupt these chains of transmission, there is an urgent need for devices that can be deployed to inactivate the virus on both recently and existing contaminated surfaces. Here, we describe the inactivation of SARS-CoV-2 in both wet and dry format using radiation generated by a commercially available Signify ultraviolet (UV)-C light source at 254 nm. We show that for contaminated surfaces, only seconds of exposure is required for complete inactivation, allowing for easy implementation in decontamination workflows. [ABSTRACT FROM AUTHOR]

Aerial survey methods for census of wildlife populations are widely used to manage species. There has been considerable research to develop methods to cope with imperfect detection during aerial surveys, however misidentification remains an unresolved but significant issue. Using data from a comprehensive dugong aerial survey of the coastline of the Northern Territory, Australia, we assessed the influence of observer, sighting and environmental variables on probabilities of both observers in double-count, dual-observer teams detecting dugongs and dolphins ('duplicate sighting probability'), the confidence with which observers could distinguish between dugongs and dolphins, and the reliability of post-detection observations by comparing data between observers. Dolphin duplicate sighting probability varied dependent on group size, Beaufort sea state and the lateral position inside the strip-width transect in relation to the aircraft. Dugong duplicate sighting probability varied across dual-observer teams. Counts of individuals in dugong and dolphin groups were unreliable past ≈5 individuals. Observer confidence in taxon identification varied by individual observer and throughout the duration of the survey (dolphin sightings) and potentially by the lateral position inside the transect strip-width in relation to the aircraft (dugong sightings). The probability of taxon identification disagreement between observers for duplicate dugong and dolphin sightings varied with group size, and markedly if one observer was uncertain (i.e. not 100% confident) of their assigned taxon. We believe this is predominately due to the presence of Australian snubfin dolphins (Orcaella heinsohni) in the survey area, which look like dugongs when seen from a distance, momentarily. We further show that application of different data filtering scenarios for uncertain taxonomic identifications and taxon identification disagreements between dual observers produces highly variable estimates of observer-specific dugong detection probability (ranging from 0.26 to 0.80 in a single observer) and dugong abundance (x̅ ± S.D., 40% ± 25%: difference between highest and lowest estimate, relative to the lowest estimate, across different data filtering scenarios). These results are particularly relevant not only to researchers conducting dugong aerial surveys, but also for other marine mammal aerial surveys in passing mode that target sympatric, morphologically similar species. We recommend development of operating procedures and analytical methods to quantify and adjust for misidentification and uncertain taxon identifications. • Accurate species identification (ID) and counts are essential for aerial surveys. • Species detection and accurate ID varies between observers and with other variables. • Detection & Abundance estimates vary depending on how ambiguous data are filtered. • Surveys of sympatric, morphologically similar species may be similarly affected. [ABSTRACT FROM AUTHOR]

Junin (JUNV) and Machupo (MACV), two mammalian arenaviruses placed on the 2018 WHO watch list, are prevalent in South America causing Argentine and Bolivian hemorrhagic fevers (AHF and BHF), respectively. The live attenuated JUNV vaccine, Candid #1, significantly reduced the incidence of AHF. Vaccination induces neutralizing antibody (nAb) responses which effectively target GP1 (the viral attachment glycoprotein) pocket which accepts the tyrosine residue of the cellular receptor, human transferrin receptor 1 (TfR1). In spite of close genetic relationships between JUNV and MACV, variability in the GP1 receptor binding site (e.g., MACV GP1 loop 10) results in poor MACV neutralization by Candid #1-induced nAbs. Candid #1 is not recommended for vaccination of children younger than 15 years old (a growing "at risk" group), pregnant women, or other immunocompromised individuals. Candid #1's primary reliance on limited missense mutations for attenuation, genetic heterogeneity, and potential stability concerns complicate approval of this vaccine in the US. To address these issues, we applied alphavirus RNA replicon vector technology based on the human Venezuelan equine encephalitis vaccine (VEEV) TC-83 to generate replication restricted virus-like-particles vectors (VLPVs) simultaneously expressing cellular glycoprotein precursors (GPC) of both viruses, JUNV and MACV. Resulting JV&MV VLPVs were found safe and immunogenic in guinea pigs. Immunization with VLPVs induced humoral responses which correlated with complete protection against lethal disease after challenge with pathogenic strains of JUNV (Romero) and MACV (Carvallo). [ABSTRACT FROM AUTHOR]

Simian-human immunodeficiency virus (SHIV) infection in rhesus macaques (RMs) resembles human immunodeficiency virus type 1 (HIV-1) infection in humans and serves as a tool to evaluate candidate AIDS vaccines. HIV-1 clade A (HIV-A) predominates in parts of Africa. We constructed an R5 clade A SHIV (SHIV-A; strain SHIV-KNH1144) carrying env from a Kenyan HIV-A. SHIV-A underwent rapid serial passage through six RMs. To allow unbridled replication without adaptive immunity, we simultaneously ablated CD8+ and B cells with cytotoxic monoclonal antibodies in the next RM, resulting in extremely high viremia and CD4+ T-cell loss. Infected blood was then transferred into two non-immune-depleted RMs, where progeny SHIV-A showed increased replicative capacity and caused AIDS. We reisolated SHIV-KNH1144p4, which was replication-competent in peripheral blood mononuclear cells (PBMC) of all RMs tested. Next-generation sequencing of early and late-passage SHIV-A strains identified mutations that arose due to "fitness" virus optimization in the former and mutations exhibiting signatures typical for adaptive host immunity in the latter. "Fitness" mutations are best described as mutations that allow for better fit of the HIV-A Env with SIV-derived virion building blocks or host proteins and mutations in non-coding regions that accelerate virus replication, all of which result in the outgrowth of virus variants in the absence of adaptive T-cell and antibody-mediated host immunity. [ABSTRACT FROM AUTHOR]

Ebola virus (EBOV) is a filovirus that can cause Ebola virus disease (EVD). No approved vaccines or therapies exist for filovirus infections, despite an urgent need. The development and testing of effective countermeasures against EBOV requires use of animal models and a thorough understanding of how the model aligns with EVD in humans. The majority of published studies report outcomes of parenteral exposures for emulating needle stick transmission. However, based on data from EVD outbreaks, close contact exposures to infected bodily fluid seems to be one of the primary routes of EBOV transmission. Thus, further work is needed to develop models that represent mucosal exposure. To characterize the outcome of mucosal exposure to EBOV, cynomolgus macaques were exposed to EBOV via intranasal (IN) route using the LMA® mucosal atomization device (LMA® MAD). For comparison, four non-human primates (NHPs) were exposed to EBOV via intramuscular (IM) route. This IN exposure model was uniformly lethal and correlated with a statistically significant delay in time to death when compared to exposure via the IM route. This more closely reflects the timeframes observed in human infections. An IN model of exposure offers an attractive alternative to other models as it can offer insight into the consequences of exposure via a mucosal surface and allows for screening countermeasures via a different exposure route. [ABSTRACT FROM AUTHOR]

The article discusses that recurrent antibody responses are driven by germline-encoded amino acid–binding (GRAB) motifs, a germline-encoded component of the architecture of the antibody repertoire that predisposes antibodies to recognize particular structures and influences epitope selection and composition. Public epitopes are best aligned for recognition by GRAB motifs and can be bound by a relatively large precursor pool of B cells.

UL24 is conserved among all Herpesviridae . In herpes simplex virus 1 (HSV-1), UL24 mutations lead to reduced viral titers both in cell culture and in vivo , and reduced pathogenicity. The human cytomegalovirus ortholog of UL24 has a gene regulatory function; however, it is not known whether other UL24 orthologs also affect gene expression. We discovered that in co-transfection experiments, expression of UL24 correlated with a reduction in the expression of several viral proteins and transcripts. Substitution mutations targeting conserved residues in UL24 impaired this function. Reduced transcript levels did not appear attributable to changes in mRNA stability. The UL24 ortholog of Herpes B virus exhibited a similar activity. An HSV-1 mutant that does not express UL24 produced more viral R1 and R2 transcripts than the wild type or rescue virus relative to the amount of viral DNA. These results reveal a new role for HSV-1 UL24 in regulating viral mRNA accumulation. [ABSTRACT FROM AUTHOR]

Ebola virus (EBOV) is an RNA virus that can cause hemorrhagic fever with high fatality rates, and there are no approved vaccines or therapies. Typically, RNA viruses have high spontaneous mutation rates, which permit rapid adaptation to selection pressures and have other important biological consequences. However, it is unknown if filoviruses exhibit high mutation frequencies. Ultradeep sequencing and a recombinant EBOV that carries the gene encoding green fluorescent protein were used to determine the spontaneous mutation frequency of EBOV. The effects of the guanosine analogue ribavirin during EBOV infections were also assessed. Ultradeep sequencing revealed that the mutation frequency for EBOV was high and similar to those of other RNA viruses. Interestingly, significant genetic diversity was not observed in viable viruses, implying that changes were not well tolerated. We hypothesized that this could be exploited therapeutically. In vitro, the presence of ribavirin increased the error rate, and the 50% inhibitory concentration (IC50) was 27 μM. In a mouse model of ribavirin therapy given pre-EBOV exposure, ribavirin treatment corresponded with a significant delay in time to death and up to 75% survival. In mouse and monkey models of therapy given post-EBOV exposure, ribavirin treatment also delayed the time to death and increased survival. These results demonstrate that EBOV has a spontaneous mutation frequency similar to those of other RNA viruses. These data also suggest a potential for therapeutic use of ribavirin for human EBOV infections. IMPORTANCE Ebola virus (EBOV) causes a severe hemorrhagic disease with high case fatality rates; there are no approved vaccines or therapies. We determined the spontaneous mutation frequency of EBOV, which is relevant to understanding the potential for the virus to adapt. The frequency was similar to those of other RNA viruses. Significant genetic diversity was not observed in viable viruses, implying that changes were not well tolerated. We hypothesized that this could be exploited therapeutically. Ribavirin is a viral mutagen approved for treatment of several virus infections; it is also cheap and readily available. In cell culture, we showed that ribavirin was effective at reducing production of infectious EBOV. In mouse and monkey models of therapy given post-EBOV exposure, ribavirin treatment delayed the time to death and increased survival. These data provide a better understanding of EBOV spontaneous mutation and suggest that ribavirin may have great value in the context of human disease. [ABSTRACT FROM AUTHOR]

• Ultrafine RuNPs are stabilised by amino-modified polymer immobilized ionic liquid. • High activity for hydrolytic evolution of hydrogen from NaBH 4. • Kinetic studies confirm the hydrolysis is first order in catalyst and hydride. • Kinetic isotope studies with H 2 O/D 2 O and NaBH 4 /NaBD 4 support the proposed mechanism. • High activity retained over five reuses with only a minor reduction in conversion. Ruthenium nanoparticles stabilised by polymer immobilized ionic liquids catalyse the hydrolytic release of hydrogen from sodium borohydride. The composition of the polymer influences performance and ruthenium nanoparticles stabilised by an amine-decorated imidazolium-based polymer immobilised ionic liquid (RuNP@NH 2 -PIILS) was the most efficient with a maximum initial turnover frequency (TOF) of 177 mole H2.mol Ru −1.min−1, obtained at 30°C with a catalyst loading of 0.08 mol%; markedly higher than that of 69 mol H2.mol Ru −1.min−1 obtained with 5 wt% Ru/C and one of the highest to be reported for a RuNP catalyst. The apparent activation energy (Ea) of 38.9 kJ mol−1 for the hydrolysis of NaBH 4 catalysed by RuNP@NH 2 -PIILS is lower than that for the other polymer immobilized ionic liquid stabilised RuNPs, which is consistent with its efficacy. Comparison of the initial rates of hydrolysis in H 2 O and D 2 O catalysed by RuNP@NH 2 -PIILS gave a primary kinetic isotope effect (k H / k D) of 2.3 which supports a mechanism involving rate limiting oxidative addition of one of the O-H bonds in a strongly hydrogen-bonded surface-coordinated [BH 3 H−]—-H 2 O ensemble. The involvement of a surface-coordinated borohydride is further supported by an inverse kinetic isotope effect of 0.65 obtained from a comparison of the initial rates for the hydrolysis of NaBH 4 and NaBD 4 under the conditions of catalysis i.e., at a high hydride/catalyst mole ratio. Interestingly though, when the comparison of the initial rates of hydrolysis of NaBH 4 and NaBD 4 was conducted in dilute solution with a hydride/catalyst mole ratio of 1 a kinetic isotope effect (k H / k D) of 2.72 was obtained; this would be more consistent with concerted activation of both an O-H and B-H bond in the rate limiting step, possibly via a concerted oxidative addition-hydride transfer in the surface-coordinated hydrogen-bonded ensemble. Catalyst stability and reuse studies showed that RuNP@NH 2 -PIILS retained 71% of its activity over five runs; the gradual drop in the initial TOF with run number appears to be due to passivation of the catalyst by the sodium borate by-product as well as an increase in viscosity of the reaction mixture rather than leaching of the catalyst. [Display omitted] [ABSTRACT FROM AUTHOR]

This study addresses the role of Ebola virus (EBOV) specific infectivity in virulence. Filoviruses are highly lethal, enveloped, single- stranded negative-sense RNA viruses that can cause hemorrhagic fever. No approved vaccines or therapies exist for filovirus infections, and infectious virus must be handled in maximum containment. Efficacy testing of countermeasures, in addition to investigations of pathogenicity and immune response, often requires a well-characterized animal model. For EBOV, an obstacle in performing accurate disease modeling is a poor understanding of what constitutes an infectious dose in animal models. One well-recognized consequence of viral passage in cell culture is a change in specific infectivity, often measured as a particle-to- PFU ratio. Here, we report that serial passages of EBOV in cell culture resulted in a decrease in particle-to-PFU ratio. Notably, this correlated with decreased potency in a lethal cynomolgus macaque (Macaca fascicularis) model of infection; animals were infected with the same viral dose as determined by plaque assay, but animals that received more virus particles exhibited increased disease. This suggests that some particles are unable to form a plaque in a cell culture assay but are able to result in lethal disease in vivo. These results have a significant impact on how future studies are designed to model EBOV disease and test countermeasures. [ABSTRACT FROM AUTHOR]

Macacine herpesvirus 1 (MaHV1; B virus) naturally infects macaques (Macaca spp.) and can cause fatal encephalitis in humans. In Peninsular Malaysia, wild macaques are abundant, and translocation is used to mitigate human-macaque conflict. Most adult macaques are infected with MaHV1, although the risk for transmission to persons who handle them during capture and translocation is unknown. We investigated MaHV1 shedding among 392 long-tailed macaques (M. fascicularis) after capture and translocation by the Department of Wildlife and National Parks in Peninsular Malaysia, during 2009-2011. For detection of MaHV1 DNA, PCR was performed on urogenital and oropharyngeal swab samples. Overall, 39% of macaques were shedding MaHV1 DNA; rates of DNA detection did not differ between sample types. This study demonstrates that MaHV1 was shed by a substantial proportion of macaques after capture and transport and suggests that persons handling macaques under these circumstances might be at risk for exposure to MaHV1. [ABSTRACT FROM AUTHOR]

Abstract: Hydrous ferric oxide (here termed ‘ochre’) sludge, an abundant waste product produced from the treatment of acid mine drainage (AMD), was used in this study for the removal of phosphorus (in the form of phosphate ions) from contaminated waters. The phosphorus uptake capacities of both raw and pelletized AMD solids were compared using batch and column tests. Addition of a cement binder to the AMD solids during pellet production led to significantly increased P-loading of the resultant solids compared to the raw sludge. Additionally, the pellets were found to continue to remove P in tests up to 7d in duration whereas the unbound AMD sludge appeared to approach equilibrium with phosphate solution after approximately 60min of contact time. In line with previous studies P uptake by the AMD solids was found to be primarily via adsorption. By contrast calcium phosphate precipitation was found to be the dominant removal mechanism for the cement-bound ochre pellets with a relatively small proportion of removal attributable to the AMD solids. SEM–EDX analysis of the surface of used pellets showed a Ca:P molar ratio close to that of hydroxyapatite (HAP). Continuous column tests on these pellets showed a rapid decrease in P removal capacity by the pellets over time, attributable to the formation of a passivating HAP surface layer. [Copyright &y& Elsevier]

Abstract: Producer gas is a form of synthesis gas formed from the gasification of biomass. Its composition varies largely depending on the gasifier type, up-draft, down-draft and entrained flow to name a few, and oxidiser, typically air, steam or pure oxygen. The producer gas in question is derived from an air fed down-draft gasifier containing Grade-A wood waste, and as such has comparatively low calorific value and hydrogen content of around 6MJ/Nm3 and 11% respectively. The viability of producing thermal energy on an industrial scale was proved via the swirl-stabilised combustion of forementioned producer gas in a 1.5MW rated swirl burner, directly attached to a proprietary gasification plant. A largely stable combustion was achieved; however, a few instances of flame extinction did occur which were attributed to varying fluctuations in gasifier throat temperature. A relationship between throat temperature and fuel composition is believed to be the cause of these extinctions. Although these fluctuations were shown to have little effect on the producer gases stoichiometric air-to-fuel ratio and calorific value, there was particular variance in hydrogen content. Simulation using CHEMKIN showed that this variable hydrogen content had a significant effect on flame speed, with an increase from 5% to 15% hydrogen increasing laminar flame speed from 8.01cm/s to 17.70cm/s. Industrial-scale data was also compared to that taken with a 100kW laboratory-scale combustor in an attempt to establish whether burner optimisation could be effectively achieved in a controlled laboratory environment. A relationship was found between exhaust temperature and introduction of axial air, which extended across both burners. Flame speed and flame temperature simulations also showed that air is an acceptable diluent of natural gas when substituting for producer gas. [Copyright &y& Elsevier]

We describe herein, limitations on research at biosafety level 4 (BSL-4) containment laboratories, with regard to biosecurity regulations, safety considerations, research space limitations, and physical constraints in executing experimental procedures. These limitations can severely impact the number of collaborations and size of research projects investigating microbial pathogens of biodefense concern. Acquisition, use, storage, and transfer of biological select agents and toxins (BSAT) are highly regulated due to their potential to pose a severe threat to public health and safety. All federal, state, city, and local regulations must be followed to obtain and maintain registration for the institution to conduct research involving BSAT. These include initial screening and continuous monitoring of personnel, controlled access to containment laboratories, accurate and current BSAT inventory records. Safety considerations are paramount in BSL-4 containment laboratories while considering the types of research tools, workflow and time required for conducting both in vivo and in vitro experiments in limited space. Required use of a positive-pressure encapsulating suit imposes tremendous physical limitations on the researcher. Successful mitigation of these constraints requires additional time, effort, good communication, and creative solutions. Test and evaluation of novel vaccines and therapeutics conducted under good laboratory practice (GLP) conditions for FDA approval are prioritized and frequently share the same physical space with important ongoing basic research studies. The possibilities and limitations of biomedical research involving microbial pathogens of biodefense concern in BSL-4 containment laboratories are explored in this review. [ABSTRACT FROM AUTHOR]

The filovirus plaque assay serves as the assay of choice to measure infectious virus in a cell culture, blood, or homogenized tissue sample. It has been in use for more than 30 years and is the generally accepted assay used to titrate virus in samples from animals treated with a potential antiviral therapeutic or vaccine. As these animal studies are required for the development of vaccines and therapeutics under the FDA Animal Rule, it is essential to have a standardized assay to compare their efficacies against the various filoviruses. Here, we present an evaluation of the conditions under which the filovirus plaque assay performs best for the Ebola virus Kikwit variant and the Angola variant of Marburg virus. The indicator cell type and source, inoculum volumes, length of incubation and general features of filovirus biology as visualized in the assay are addressed in terms of the impact on the sample viral titer calculations. These optimization studies have resulted in a plaque assay protocol which can be used for preclinical studies, and as a standardized protocol for use across institutions, to aid in data comparison. This protocol will be validated for use in GLP studies supporting advanced development of filovirus therapeutics and vaccines. [ABSTRACT FROM AUTHOR]

This article provides a context to, attempts an explanation for, and proposes a response to the recent demonstration of rapid and severe decline of the native mammal fauna of Kakadu National Park. This decline is consistent with, but might be more accentuated than, declines reported elsewhere in northern Australia; however, such a comparison is constrained by the sparse information base across this region. Disconcertingly, the decline has similarities with the earlier phase of mammal extinctions that occurred elsewhere in Australia. We considered four proximate factors (individually or interactively) that might be driving the observed decline: habitat change, predation (by feral cats), poisoning (by invading cane toads), and novel disease. No single factor readily explains the current decline. The current rapid decline of mammals in Kakadu National Park and northern Australia suggests that the fate of biodiversity globally might be even bleaker than evident in recent reviews, and that the establishment of conservation reserves alone is insufficient to maintain biodiversity. This latter conclusion is not new; but the results reported here further stress the need to manage reserves far more intensively, purposefully, and effectively, and to audit regularly their biodiversity conservation performance. [ABSTRACT FROM AUTHOR]

Herpes B virus (BV) naturally infects macaque monkeys and is a close relative of herpes simplex virus. BV can zoonotically infect humans to cause a rapidly ascending encephalitis with ~80% mortality. Therefore, BV is a serious danger to those who come into contact with these monkeys or their tissues and cells. MicroRNAs are regulators of gene expression, and there have been reports of virus-encoded microRNAs. We hypothesize that BV-encoded microRNAs are important for the regulation of viral and cellular genes. Herein, we report the discovery of three herpes B virus-encoded microRNAs. [ABSTRACT FROM AUTHOR]

Biomaterials and Oxygen Join Forces to Shape the Immune Response and Boost COVID-19 Vaccines (Adv. Sci. 18/2021) B COVID-19 Vaccines b In article number 2100316 by Sidi A. Bencherif and co-workers, it is demonstrated that advanced biomaterials can be leveraged to boost the effectiveness of SARS-CoV-2 protein subunit vaccines. Illustration depicting a subcutaneously injected oxygen-releasing cryogel-based COVID-19 vaccine boosting the immune response, leading to a sustained production of highly effective neutralizing antibodies against SARS-CoV-2. [Extracted from the article]

Summary 1.The indicator qualities of terrestrial invertebrates are widely recognized in the context of detecting ecological change associated with human land-use. However, the use of terrestrial invertebrates as bioindicators remains more a topic of scientific discourse than a part of land-management practice, largely because their inordinate numbers, taxonomic challenges and general unfamiliarity make invertebrates too intimidating for most land-management agencies. Terrestrial invertebrates will not be widely adopted as bioindicators in land management until simple and efficient protocols have been developed that meet the needs of land managers. 2.In Australia, ants are one group of terrestrial insects that has been commonly adopted as bioindicators in land management, and this study examined the reliability of a simplified ant assessment protocol designed to be within the capacity of a wide range of land managers. 3.Ants had previously been surveyed intensively as part of a comprehensive assessment of biodiversity responses to SO2 emissions from a large copper and lead smelter at Mt Isa in the Australian semi-arid tropics. This intensive ant survey yielded 174 species from 24 genera, and revealed seven key patterns of ant community structure and composition in relation to habitat and SO2 levels. 4.We tested the extent to which a greatly simplified ant assessment was able to reproduce these results. Our simplified assessment was based on ant ‘bycatch’ from bucket-sized (20-litre) pitfall traps used to sample vertebrates as part of the broader biodiversity survey. We also greatly simplified the sorting of ant morphospecies by considering only large (using a threshold of 4 mm) species, and we reduced sorting time by considering only the presence or absence of species at each site. In this manner, the inclusion of ants in the assessment process required less than 10% of the effort demanded by the intensive ant survey. 5.Our... [ABSTRACT FROM AUTHOR]

Many individuals mount nearly identical antibody responses to SARS-CoV-2. To gain insight into how the viral spike (S) protein receptor-binding domain (RBD) might evolve in response to common antibody responses, we studied mutations occurring during virus evolution in a persistently infected immunocompromised individual. We use antibody Fab/RBD structures to predict, and pseudotypes to confirm, that mutations found in late-stage evolved S variants confer resistance to a common class of SARS-CoV-2 neutralizing antibodies we isolated from a healthy COVID-19 convalescent donor. Resistance extends to the polyclonal serum immunoglobulins of four out of four healthy convalescent donors we tested and to monoclonal antibodies in clinical use. We further show that affinity maturation is unimportant for wild-type virus neutralization but is critical to neutralization breadth. Because the mutations we studied foreshadowed emerging variants that are now circulating across the globe, our results have implications to the long-term efficacy of S-directed countermeasures. [Display omitted] • SARS-CoV-2 spike evolves during persistent infection to resist common antibodies • Antibody affinity maturation is critical to neutralization breadth • Intra-host evolution foreshadows mutations in circulating spike variants Structural and functional analysis of the evolution of SARS-CoV-2 in a persistently infected immunocompromised individual yields insights into mutations that foreshadow emerging viral variants worldwide. [ABSTRACT FROM AUTHOR]

The filoviruses Ebola virus (EBOV) and Sudan virus (SUDV) can cause severe diseases, and there are currently no licensed countermeasures available for use against them. Transmission occurs frequently via contact with bodily fluids from infected individuals. However, it can be difficult to determine when or how someone became infected, or the quantity of infectious virus to which they were exposed. Evidence suggests the infectious dose is low, but the majority of published studies use high exposure doses. This study characterized the outcome of exposure to a low dose of EBOV or SUDV, using a Macaca fascicularis model. Further, because the effect of virus passage in cell culture may be more pronounced when lower exposure doses are used, viruses that possessed either the characteristics of wild type viruses (possessing predominantly 7-uridine (7U) genotype and a high particle-to-plaque forming unit (PFU) ratio) or cell culture-passaged viruses (predominantly 8-uridine (8U) genotype, a lower particle-to-PFU ratio) were used. The time to death after a low dose exposure was delayed in comparison to higher exposure doses. These data demonstrated that an extremely low dose of EBOV or SUDV is sufficient to cause lethal disease. A low dose exposure model can help inform studies on pathogenesis, transmission, and optimization of prevention strategies. [ABSTRACT FROM AUTHOR]

Quantitative measurement of viral load is an important parameter in the management of filovirus disease outbreaks because viral load correlates with severity of disease, survival, and infectivity. During the ongoing Ebola virus disease outbreak in parts of Western Africa, most assays used in the detection of Ebola virus disease by more than 44 diagnostic laboratories yielded qualitative results. Regulatory hurdles involved in validating quantitative assays and the urgent need for a rapid Ebola virus disease diagnosis precluded development of validated quantitative assays during the outbreak. Because of sparse quantitative data obtained from these outbreaks, opportunities for study of correlations between patient outcome, changes in viral load during the course of an outbreak, disease course in asymptomatic individuals, and the potential for virus transmission between infected patients and contacts have been limited. We strongly urge the continued development of quantitative viral load assays to carefully evaluate these parameters in future outbreaks of filovirus disease. [ABSTRACT FROM AUTHOR]

Sudan virus (SUDV), like the closely related Ebola virus (EBOV), is a filovirus that causes severe hemorrhagic disease. They both contain an RNA editing site in the glycoprotein gene that controls expression of soluble and full-length protein. We tested the consequences of cell culture passage on the genome sequence at the SUDV editing site locus and determined whether this affected virulence. Passage resulted in expansion of the SUDV editing site, similar to that observed with EBOV. We compared viruses possessing either the wild-type or expanded editing site, using a nonhuman primate model of disease. Despite differences in virus serum titer at one time point, there were no significant differences in time to death or any other measured parameter. These data imply that changes at this locus were not important for SUDV lethality. [ABSTRACT FROM AUTHOR]

To investigate the requirements of herpesvirus entry and fusion, the four homologous glycoproteins necessary for herpes simplex virus (HSV) fusion were cloned from herpes B virus (BV) (or macacine herpesvirus 1, previously known as cercopithecine herpesvirus 1) and cercopithecine herpesvirus 2 (CeHV-2), both related simian simplexviruses belonging to the alphaherpesvirus subfamily. Western blots and cell-based enzyme-linked immunosorbent assay (ELISA) showed that glycoproteins gB, gD, and gH/gL were expressed in whole-cell lysates and on the cell surface. Cell-cell fusion assays indicated that nectin-1, an HSV-1 gD receptor, mediated fusion of cells expressing glycoproteins from both BV and CeHV-2. However, herpesvirus entry mediator (HVEM), another HSV-1 gD receptor, did not facilitate BV- and CeHV-2-induced cell-cell fusion. Paired immunoglobulin-like type 2 receptor alpha (PILRa), an HSV-1 gB fusion receptor, did not mediate fusion of cells expressing glycoproteins from either simian virus. Productive infection with BV was possible only with nectin-1-expressing cells, indicating that nectin-1 mediated entry while HVEM and PILRa did not function as entry receptors. These results indicate that these alphaherpesviruses have differing preferences for entry receptors. The usage of the HSV-1 gD receptor nectin-1 may explain interspecies transfer of the viruses, and altered receptor usage may result in altered virulence, tropism, or pathogenesis in the new host. A heterotypic cell fusion assay resulting in productive fusion may provide insight into interactions that occur to trigger fusion. These findings may be of therapeutic significance for control of deadly BV infections. [ABSTRACT FROM AUTHOR]

A single-cytosine-deletion in the herpes simplex virus gene encoding thymidine kinase (TK) was previously found in an acyclovir-resistant clinical isolate. A laboratory strain engineered to carry this mutation did not generate sufficient TK activity for detection by plaque autoradiography, which detected 0.25% wild-type activity. However, a drug sensitivity assay suggested that extremely low levels of TK are generated by this virus. The virus was estimated to express 0.09% of wild-type TK activity via a ribosomal frameshift 24 nucleotides upstream of the mutation. Remarkably, this appeared to be sufficient active TK to support a low level of reactivation from latently infected mouse trigeminal ganglia. [ABSTRACT FROM AUTHOR]